TibaRay Secures New Corporate Headquarters with Integrated Radiation Vault

TibaRay recently signed a multi-year lease agreement to secure a 24,000 square foot facility in Fremont, CA to serve as the Company’s future headquarters. The Fremont facility is well-suited to TibaRay’s long-term strategic plan, as it includes a pre-existing radiation vault ideal for future development of the Company’s novel PHASER radiotherapy system and its components. The Company will transition from its existing facility in Santa Clara, CA to the Fremont facility in the coming months of 2023.

“Our new corporate headquarters in Fremont will allow us to expand our design capabilities, increase our manufacturing capacity of differentiated radio frequency components, and serve as the foundation to begin development of our novel PHASER radiotherapy treatment system,” says Jeff Amacker, Chief Executive Officer of TibaRay. “This strategic investment underscores our long-term commitment to deliver faster, more effective cancer treatment with less collateral damage to healthy tissues for patients with all types and stages of cancer, all over the world.”